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Abstract
Background: Short oligonucleotide arrays have several probes measuring the expression level of
each target transcript. Therefore the selection of probes is a key component for the quality of
measurements. However, once probes have been selected and synthesized on an array, it is still
possible to re-evaluate the results using an updated mapping of probes to genes, taking into account
the latest biological knowledge available.
Methods: We investigated how probes found on recent commercial microarrays for human genes
(Affymetrix HG-U133A) were matching a recent curated collection of human transcripts: the NCBI
RefSeq database. We also built mappings and used them in place of the original probe to genes
associations provided by the manufacturer of the arrays.
Results: In a large number of cases, 36%, the probes matching a reference sequence were
consistent with the grouping of probes by the manufacturer of the chips. For the remaining cases
there were discrepancies and we show how that can affect the analysis of data.
Conclusions: While the probes on Affymetrix arrays remain the same for several years, the
biological knowledge concerning the genomic sequences evolves rapidly. Using up-to-date
knowledge can apparently change the outcome of an analysis.
Background
In a relatively short time microarrays have become a well
established technique, widely used by researchers. Micro-
arrays offer nothing less than to be able to monitor simul-
taneously the expression levels for thousands of genes.
The RNA molecules from the biological sample are called
targets, and the polymers of nucleic acids fixed on the sur-
face are called probes. The very large number of genes rep-
resented on each microarray requires the use of computer
based approaches. Although such approaches currently
constitute a very rich and active area of research, for many
data analyses this step can be summarized simply: under
the prior assumption that for the large majority of the
genes represented on a microarray the expression will not
vary significantly across experiments, the main focus is be
to isolate the few genes of interest from the rest. Short oli-
gonucleotide arrays are a particular type of microarrays.
Short oligonucleotide arrays are constituted of short
probes (oligonucleotides) with several probes designed to
match different part of the target sequences. The use of
techniques originating from the micro-electronics
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industry proved very successful in the making of short oli-
gonucleotides arrays [1], helping the Affymetrix company
establish itself as one of the primary manufacturers for
microarrays. The pre-processing of oligonucleotide array
data differs from other microarray data, specifically
because probe intensities associated with each gene are
generally summarized by an expression value, or expres-
sion index. As it contributes to the computation of the
expression values, this step alone is of importance. Differ-
ent algorithms have been suggested to replace and
improve Affymetrix's original algorithms [2], including E.
Lazaridis et al.'s playerout [3], Li and Wong's model [4],
medianpolish [5], and Affymetrix's own improvements to
its algorithms [6]. However, information about the indi-
vidual probes was not disclosed until a few years ago.
Only with the release of the probe sequences for a signifi-
cant number of Affymetrix chips, data analysis approaches
considering the nature of individual probes have been
made possible. The use of the chemical nature of the
probes, on which depends the binding energy with com-
plementary sequences, has already been suggested to
improve pre-processing of Affymetrix data at the probe
level [7,8].
The annotation for sequenced genomes have progressed
considerably since the design of the Affymetrix chips, even
the most recent ones, and matching the latest transcrip-
tomic (or genomic) data available with the chip designs is
an obvious thing to do.
We have performed such a remapping for a few Affymetrix
chips, and we show that the resulting probe-to-gene map-
ping can differ substantially from the original Affymetrix
mapping. This can affect the interpretation of experimen-
tal data.
As annotations of genomes continue to evolve, it is also
desirable to have a framework to perform and handle up-
to-date probe-to-gene mapping. We provide an open
source and documented implementation to do so.
Results
The results obtained are subdivided in two main catego-
ries: the matches between probes and reference sequence
obtained, and the difference in the outcome of an analysis
when using an alternative mapping.
Probes matching multiple RefSeq entries
A fair number of probes were found to match several ref-
erence sequences, as shown in Figure 1.
For example, the RefSeq NM_001544.2 is found to have
21 matching probes. Eleven of these matching probes also
match another reference sequence: NM_022377.1. A
quick look at the annotation reveals that both reference
sequences are two different transcripts variants of the
same gene 'Homo sapiens intercellular adhesion mole-
cule 4, Landsteiner-Wiener blood group (ICAM4)' and
that the same probes are found matching these two
sequences. However the ten remaining probes matching
NM_001544.2 are also found matching a fairly large
number of other reference sequences (from a little less
than 300 to almost 600 reference sequences, depending
on the probe). We found that these probes are designed to
Histrograms for the number of probes per probe setFigure 1
Histrograms for the number of probes per probe set. 
Both plots are histogram, the values on the y axis are relative 
frequencies. (top) Histogram of the number of probes on the 
U133A chip matching a particular RefSeq transcript. A clear 
peak can be seen for 11 probes, which corresponds to the 
number of probes in a probe set most commonly found in 
the original mapping. This set is called Alt1 in the last part of 
the section Results. (bottom) Histogram of number of Ref-
Seq transcripts matching a single probe (log scale). Most of 
the probes can be seen matching only one RefSeq. In both 
plots, the probes associated to human 'ALU' repeats were fil-
tered out.
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match sub-sequences frequently found in mRNA: ALU
repeats. All the probes matching ALU repeats are in the
official mapping grouped in a common probe set, called
'human ALU'.
Besides 'human ALU' probes, other probes matching mul-
tiple reference sequences were found. In that case, the ref-
erence sequences matching a given probe have closely
related annotations, or even identical annotations. Com-
plex mixtures of partial overlaps for the probe sets can
then be observed. As an example, the probe 88322 is
found matching the reference sequences NM_017445.1,
NM_003519.3, NM_003520.3, NM_003521.2,
NM_003525.2, NM_003528.2, NM_080593.1 and
XM_301109.1, annotated 'H2B histone family, member S
(H2BFS), mRNA', 'histone 1, H2bl (HIST1H2BL), mRNA',
'histone 1, H2bn (HIST1H2BN), mRNA', 'histone 1,
H2bm (HIST1H2BM), mRNA', 'histone 1, H2bi
(HIST1H2BI), mRNA', 'histone 2, H2be (HIST2H2BE),
mRNA', 'histone 1, H2bk (HIST1H2BK), mRNA' and 'sim-
ilar to Histone H2B 291B (LOC350694), mRNA'
respectively.
Such matches in each case require expert annotators to
curate the alternative mappings, so we chose to simply
ignore the probes matching several reference sequences in
the rest of this study.
Other multiple matches are more easy to handle, and
potentially more harmful when included in an analysis.
Some probes are found to hybridize to several unrelated
reference sequences, as shown in Figure 2. Only 290
probes that were labeled mismatches in the official map-
ping, were found to be legitimate perfect match probes in
the alternative mapping.
Reference sequences matching the probe 122174Figure 2
Reference sequences matching the probe 122174. 
The reference sequences matching the probe 122174, 
assigned to the probe set 211697_x_at and annotated 'Homo 
sapiens RNA-binding protein LOC56902 mRNA, complete 
cds' in the original mapping. NCBI's reference sequences are 
annotated 'paraneoplastic antigen MA2 (PNMA2), mRNA', 
'LOC202934 (LOC202934), mRNA', 'hypothetical protein 
LOC283507 (LOC283507), mRNA', 'sarcalumenin (SRL), 
mRNA', 'LOC284095 (LOC284095), mRNA', 'putative 28 
kDa protein (LOC56902), mRNA' and 'sodium channel, volt-
age-gated, type III, beta (SCN3B), mRNA' respectively
Probes, probe sets and reference sequenceFigure 3
Probes, probe sets and reference sequence. Reference 
sequence matching all the probes from probe sets in the offi-
cial mapping. The reference sequence is represented by a 
long dark cylinder, while the matching probes are repre-
sented by red or yellow fragments of cylinder. The wire 
frame represents the grouping of probes in a probe set in the 
official mapping. (Top:) All the probes matching the reference 
sequence constitute a probe set in the official mapping. (Bot-
tom:) All the probes matching the reference sequence con-
stitute two different probe sets in the official mapping.
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Reference sequences matching all the probes from probe 
sets
We also found a significant number of reference
sequences for which all the matching probes belong to
one probe set in the official mapping. When a 'one to one'
association can be established between a probe set of the
official mapping and a probe set in an alternative mapping,
which means that a given reference sequence matches all
the probes associated with one Affymetrix ID, we conclude
a complete agreement between the alternative mapping and
the official one (See Figure 3, top). That is the case for 6274
out of 17426 reference sequences (17426 is the number of
reference sequences for which at least one matching probe
was found). When the association is 'one-to-many', in the
sense that several complete probe sets in the original map-
ping are matching one reference sequence, one could con-
clude that, alternative splicing events left aside, some
probe sets are redundant (See Figure 3, bottom).
We obtain 1168, 212, 38, 4 and 2 reference sequences for
which the matching probes are coming from 2, 3, 4, 5 and
6 original probe sets respectively. The Figure 4 shows that
it represents a significant part of the cases. This represents
8% of the original probe sets of a HG-U133A that are
potentially redundant.
Effect on the outcome of an analysis
Naturally the expression values, or expression indexes,
computed from the probes intensities are sensitive to dif-
ferences in the mapping: different probes will give differ-
ent summary expression values, which can have an effect
on the outcome of an analysis. To verify it, we performed
a standard exploratory analysis of Affymetrix data (two
samples, looking for the genes that are significantly differ-
entially expressed). The probe level intensities were pre-
processed and expression values computed. The original
mapping was used to obtain a first set of expression values
(set Affy), while the alternative mappings made from
matching NCBI's reference sequences was used to obtain
two more sets of expression values (sets Alt1 and Set Alt2),
using all the matching probes or all the probes matching
uniquely respectively. In other words, the set Alt2 differs
from the set Alt1 in the sense that probes in Alt1 matching
several reference sequences were removed from Alt2. The
set Affy describes 22283 probe sets, the set Alt1 describes
18076 probe sets (for a total of 184735 probes) and the
set Alt2 11640 probe sets (for a total of 153257 probes).
The number of mismatch probes in the official mapping
that are found in the alternative mappings is low: 290 in
Alt1 and 87 in Alt2.
For each one of the three sets, 'significantly differentially
expressed genes' (SDEGs) are searched for: a Welch's two-
sample t-test is performed on all the expression values in
each set, and the selection for significant p-values done as
described by Ventura and collaborators [9,10] (qvalue set
to 1%). The number of SDEGs obtained in the sets Affy,
Alt1 and Alt2 are 163, 163, and 103 respectively. Table 1
shows how many of these represent identical probe sets.
However, there is also a significant fraction of probe sets
for which no simple equivalence could be made. As
shown when discussing the matches, the situation is
rather complex and a detailed examination for each case
would be needed before a comparison between the map-
pings is possible. The presence of mismatch probes in the
alternative mappings does not appear to have much
influence. A legitimate concern can be that some of the
probe sets in the alternative mappings only contain one or
Scatter plots for the number of probes matching a reference sequ nceFig re 4
Scatter plots for the number of probes matching a 
reference sequence. Scatter plot of the total number of 
probes matching a reference sequence against the number of 
probes remaining after removing the probes matching several 
reference sequences. Colored areas are displayed to indicate 
the z-axis, the number of probes occupying each spot in the 
graph. A grid-like pattern can be observed in the lower-left 
corner of the plot. The size of the cells is 11 probes, which is 
the number of probes contained in most of the probe sets in 
the official mapping.
Table 1: Number of probe sets Number of complete probe sets 
(see Figure 3, top) in common between the sets of significantly 
differentially expressed genes (SDEGs) Affy, Alt1 and Alt2 (163, 
103 and 103 probe sets respectively).
Affy Alt1 Alt2
Affy 61 54
Alt1 61 95
Alt2 54 95
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two probes, therefore the results obtained with theses
probe sets may be dubious. In fact, only very few of these
probe sets contain a small number of probes, as shown in
Figure 5. Moreover, the minimal acceptable number of
probes in a probe set has been reported to be lower than
the number of probes commonly used [11]. Validation of
the results found with our alternative mappings will have to
be done in silico through the curation of the mappings by
expert annotators and experimentally with techniques like
RT-PCR.
Software for inter-exchange mappings
We present a complex situation, with new probe sets built
on matches between NCBI's RefSeq reference sequences
and the sequences of the short oligonucleotide probes
found on commercial arrays. This would be of little prac-
tical use for the research community without an easy
access to the data or the tools used to obtain them. The
framework developed in the package 'affy', an open-
source and documented collection of data structures and
functions for the analysis of GeneChip oligonucleotide
arrays at the probe level, is currently used by a growing
number of researchers. We take advantage of the features
it offers by providing alternative mapping objects that can
be 'plugged in', and used instead of the original ones,
whenever wanted. The Bioconductor package 'altcdfenvs'
contains helping functions, and documentation explain-
ing how to achieve this.
Discussion
We performed a matching of the Affymetrix probes
against the latest reference sequences from NCBI's RefSeq
data bank. A number of probes appear to match a large
number of reference sequences, hence to match a large
number of transcripts. When analyzing a real data set with
state-of-the-art processing methods, we observe that the
outcome of an analysis can be influenced by inaccuracies
in the probes mapping. This is a potential problem when
more and more people use 'high-throughput' procedures,
to select 'significantly important genes' in an automated
or semi-automated fashion.
We introduce an alternative mapping between probes and
identifiers, our identifiers being NCBI's RefSeq IDs, and
offer for download alternative mappings for the Affyme-
trix chips HG-U95Av2 and HG-U133A.
The affy package is a free environment to work with
Affymetrix data at the probe level. It has capabilities to
include alternative mapping and use them in a simple
way.
Our work aims at showing potential problems. Biological
expertise remains necessary to discuss the exact nature of
each match. Affymetrix offers at their NetAffx web site [12]
a tool that allows visualization of probes matching to
multiple sequences. As the annotation of the human
genome improves over time, our environment allows to
update the probe-to-gene mapping accordingly and ana-
lyze microarray data using the best biological data and
knowledge available.
The environment for alternative mappings we present
could also be of use when using GeneChips designed for a
certain organism with mRNA known to differ (a mutant
or a slightly different organism for example).
Conclusions
We built new 'probe to gene' mappings by matching the
sequences for the probes found on human Affymetrix
Histograms of the number of probes per probe in the SDEGsFigure 5
Histograms of the number of probes per probe in the 
SDEGs. Distribution of the number of probes per probe set 
in the sets of significantly differentially expressed genes for 
the set Alt1 (top) and the set Alt2 (bottom). The probe sets 
for which an identical probe set could be found in the Affy 
set are represented in red.
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GeneChip arrays against NCBI's RefSeq database of
sequences. Solely observing the distribution of the probes
matching reference sequences, and comparing the results
with the mapping provided by the manufacturer of the
chips, we found potential problems such as probes match-
ing several reference sequences and probes from different
probe sets in the official mapping matching all the same
reference sequence. Depending on the mapping used, the
outcome of the data analysis will change as different genes
may be selected as differentially expressed. We suggest
that a good mapping of probe to genes changes in time,
follows the most recent updates in sequence databases
(the databases of sequences are constantly modified, with
sequences corrected, and sometimes hypothetical gene
sequences withdrawn). We like to picture the current situ-
ation, where the mappings are frozen, as a Dorian Gray-
like syndrome: the apparent eternal youth of the mapping
does not reflect that somewhere the 'picture of it' decays.
We developed a set of open-source tools, perfectly inte-
grated to an already existing working environment for
Affymetrix arrays. The tools are documented and made
available to the research community. They let one repro-
duce our results, and build other mappings.
Methods
Reference sequences and probe sequences
The database of reference sequences used for remapping
the Affymetrix chips is NCBI's RefSeq (first release of
NCBI's RefSeq, dated June 30th, 2003), freely available for
download on the RefSeq website [13]. Only sequences
tagged as Homo sapiens mRNA are considered.
The Affymetrix chip types HG-U95Av2 and HG-U133A,
both designed for the study of the human transcriptome,
were used. While similar features were observed for both,
we focus on the HG-U133A to describe our results, as this
is the chip with the most recent design.
The probe sequences for the chips are freely available on
the Affymetrix website [14], as well as on the Bioconduc-
tor website [15] as meta-data packages. In total, there are
495930 probe sequences on the chips of type HG-U133A
(245965 perfect match probes and 245965 mismatch
probes).
Probe matching
Affymetrix GeneChips have several probes per probe set,
and a probe set usually represents a gene. Each probe is 25
bases long, and on most arrays probes are grouped in
pairs. A probe pair is constituted of a perfect match (pm)
probe, designed to match perfect a target gene sequence,
and a mismatch (mm) probe, designed to measure non-
specific hybridization. The mismatch probe differs from
its associated perfect match probe only in the 13th base.
In some cases, a probe set represents a fragment of a gene,
e.g, 3-prime and 5-prime extremities of the same gene are
used as internal control for the efficiency of the reverse
transcription. We prefer the term 'probe set ID' to 'gene'
since probe sets are not always genes. We call the associa-
tion 'probes – probe set ID' a mapping. We refer to the
grouping of probes in probe sets given by Affymetrix as the
official mapping, while a grouping of the probes matching
a reference sequence into a probe set is referred to as an
alternative mapping. The short length of the probes, as well
as several authors reporting a successful use of perfect
matches only [3-5,16], suggest that the hybridization sig-
nals coming from exact matches alone are able to capture
the expression signal reliably. We consider all the probes
(including mm) as potential pm probes to perform the
matching. The matching of a probe to a sequence is done
using the Bioconductor package matchprobes. It performs
an exact string matching, as done by the standard C library
string: only complete sequence identity between a probe
and a fragment of a reference sequence is counted as a
match.
Experimental data
We collected pancreatic tumor tissue from 8 patients and
normal pancreatic tissue from 5. Tumor samples were col-
lected from patients undergoing surgery for pancreatic
tumors, quick frozen in liquid nitrogen and kept at -80°C
until RNA extraction (the study was approved by the eth-
ical committee for Copenhagen). The tissue was homoge-
nized using a Polytron (kinematica. AG, Littau-Luzern,
Schwitzerland). 5 µg RNA was extracted from each sample
and labeled. The RNA was extracted according to the Tri-
zol protocol (Invitrogen). The samples were applied to
Affymetrix HG-U133A GeneChips according to
manufacturer's instruction. Clinical results from this
study will be published elsewhere (manuscript in
preparation).
Data processing
The probe level data are pre-processed using the affy soft-
ware package [17]. No background correction is per-
formed, and probe level intensities are normalized using
the vsn [18] normalization method. Summary expression
indexes are computed using the method medianpolish,
using only perfect match probes. The exclusive use of per-
fect match probes is needed to have an identical pre-
processing step for the official mapping and alternative
mappings, to allow comparison of the results obtained.
Availability
All the datasets and software used are freely available, and
on a wide range of platforms (Linux, Microsoft Windows,
MacOS X, other UNIX-like operating systems).
The original material used to obtain our results, software
and data, is available from the web page: Alternative
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mappings http://www.cbs.dtu.dk/staff/laurent/down
load/maprefseq/.
The package altcdfenvs, new with the Bioconductor
release 1.4 of May 2004 and available on the Bioconduc-
tor website, is designed to help researchers to build their
own alternative mappings, using their own set of reference
sequences and the probe sequences for the Affymetrix
chip of their choice.
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